Equillium to Present at H.C. Wainwright 22nd Annual Global Investment Conference
LA JOLLA, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding […]
Trius Enters Into Market-Making Agreement
FREDERICTON, New Brunswick, Sept. 03, 2020 (GLOBE NEWSWIRE) — Trius Investments Inc. (TSXV: TRU) (“Trius” or the “Company”) is pleased […]
Lyra Therapeutics to Present Data Supporting LYR-210 for the Treatment of Chronic Rhinosinusitis
WATERTOWN, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the […]
CymaBay Therapeutics to Present at Upcoming Investor Conferences
NEWARK, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing […]
Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 Inhibitor
CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the […]
Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for […]
HBT Financial, Inc. Announces Issuance of $40 Million in Subordinated Notes
BLOOMINGTON, Ill., Sept. 03, 2020 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”), the holding […]
Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference
RANCHO CUCAMONGA, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, […]
Open Lending Appoints Eric A. Feldstein to Board of Directors
AUSTIN, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) — Open Lending Corporation (NASDAQ: LPRO) (“Open Lending”), a leading provider of lending […]
Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (“Organovo” or the “Company”) (Nasdaq: ONVO) announced today that […]
